Capula Management »

BioCryst Pharmaceuticals shares owned by Capula Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Capula Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $997k 161k 6.18

More positions owned by Capula Management

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon (AMZN)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Broadcom Put Option (AVGO)
Ishares Bitcoin Tr SHS (IBIT)
Microsoft Corporation Put Option (MSFT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Advanced Micro Devices (AMD)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Capula Management

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals